GSA CAPITAL PARTNERS LLP - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q1 2020$272,000
-21.4%
18,997
+49.6%
0.07%
+70.0%
Q4 2019$346,000
+27.2%
12,700
+33.7%
0.04%
+8.1%
Q3 2019$272,000
-86.8%
9,500
-84.7%
0.04%
-82.3%
Q1 2019$2,066,000
+38.8%
62,224
+21.5%
0.21%
+21.5%
Q4 2018$1,489,000
+36.6%
51,225
+116.1%
0.17%
+186.7%
Q3 2018$1,090,000
-52.0%
23,700
-61.0%
0.06%
-46.9%
Q2 2018$2,272,000
-4.9%
60,800
-24.8%
0.11%
-10.3%
Q1 2018$2,388,000
-29.8%
80,800
-18.4%
0.13%
-39.1%
Q4 2017$3,402,000
+28.8%
99,058
+35.7%
0.21%
+15.0%
Q3 2017$2,641,000
+41.2%
73,000
+0.8%
0.18%
+47.5%
Q2 2017$1,871,000
-20.2%
72,400
-40.7%
0.12%
-3.2%
Q1 2017$2,344,000
-6.7%
122,058
-19.0%
0.13%
-16.0%
Q4 2016$2,513,000
-19.7%
150,737
-0.9%
0.15%
-10.7%
Q3 2016$3,129,000
-29.5%
152,039
+4.8%
0.17%
-31.4%
Q2 2016$4,439,000
-8.3%
145,063
+12.2%
0.24%
-20.7%
Q1 2016$4,841,000
-10.9%
129,328
+2.7%
0.31%
+16.2%
Q4 2015$5,435,000
+89.4%
125,932
+64.5%
0.27%
+88.7%
Q3 2015$2,869,000
+75.4%
76,537
+59.0%
0.14%
+123.8%
Q2 2015$1,636,000
-23.2%
48,137
-20.0%
0.06%
-25.9%
Q1 2015$2,129,000
-14.5%
60,137
-17.8%
0.08%
-51.1%
Q4 2014$2,491,000
+49.1%
73,148
+68.8%
0.17%
+97.7%
Q3 2014$1,671,000
+309.6%
43,331
+313.3%
0.09%
+388.9%
Q2 2014$408,000
-3.1%
10,485
-14.9%
0.02%
-40.0%
Q1 2014$421,000
-33.1%
12,328
-58.9%
0.03%
-40.0%
Q4 2013$629,000
-70.0%
29,963
-66.4%
0.05%
-69.9%
Q3 2013$2,095,000
+280.2%
89,156
+334.7%
0.17%
+155.4%
Q2 2013$551,00020,5080.06%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders